Search

everythinglearnresearchcommunity

for

Search:↓

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Betamethasone oral mini-pulse therapy is safe and effective for treating extensive alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

The treatment was not recommended due to limited effectiveness and significant side effects.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

PCOS treatment should be personalized based on individual symptoms and health goals.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

The paper concludes that drug labels should be clear for all, especially for those with low literacy, and suggests aiming for high comprehension test passing rates with diverse test populations.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.